Consolidated Statements of Cash Flows (Unaudited) - USD ($)
|
3 Months Ended |
Mar. 31, 2018 |
Mar. 31, 2017 |
| Cash flows from operating activities: |
|
|
| Net loss |
$ (131,389)
|
$ (232,465)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Loss (gain) from change in fair value of derivative liability |
(8,408)
|
1,021
|
| Amortization of debt discounts |
24,991
|
3,889
|
| Excess fair value of shares issued |
62,714
|
|
| Gain on disposal of assets |
(1,000)
|
|
| Share based compensation |
17,870
|
|
| Changes in operating assets and liabilities: |
|
|
| Prepaid expenses and other current assets |
2,917
|
(29,167)
|
| Accounts payable |
(1,315)
|
(4,788)
|
| Accrued liabilities |
13,369
|
106,368
|
| Net cash used in operating activities |
(20,251)
|
(155,142)
|
| Cash flows from financing activities: |
|
|
| Proceeds from line of credit/notes payable |
25,000
|
|
| Proceeds from the sale of assets |
1,000
|
|
| Net cash provided by financing activities |
26,000
|
|
| Net change in cash and cash equivalents |
5,749
|
(155,142)
|
| Cash and cash equivalents beginning of period |
67
|
161,991
|
| Cash and cash equivalents end of period |
5,816
|
6,849
|
| Supplemental schedule of non-cash investing and financing activities: |
|
|
| Relief of accrued payables and accrued liabilities through issuance of common stock. |
41,695
|
|
| Derivative liability reclassed to additional paid-in capital |
$ 43,240
|
|